Researchers & Healthcare Professionals

www.lls.org/researchershealthcareprofessionals

Did you know?

LLS Therapy Acceleration Program partner, Celator, has completed their targeted enrollment of 120 first relapsed AML patients for their phase II trial of their liposomal drug CPX-351.

Myeloma Treatment and Side Effects Management Update

Note: The free Adobe Acrobat Reader® is required to view and print Adobe PDF files, and the free Windows Media Player or RealPlayer is required to listen to the MP3 audio files.

Date: May 15, 2012
CE Credit Available Until: January 12, 2014
Location: Virtual Lecture
Read: Myeloma News | Noticias sobre el mieloma | Transcript
Download: Program Slides
Listen: Presentation | Q&A Session | Presentation/Q&A Session (Spanish)
Access: Virtual Lecture (English/Spanish)
Target Audience: Oncology nurses and social workers involved in the treatment of myeloma

Activity Purpose

To educate oncology nurses and social workers about myeloma treatment and side effects management.

Educational Objectives

At the conclusion of this program, participants should be able to:

  • Explain current and emerging treatment options for myeloma
  • Describe the importance of clinical trials in improving myeloma patient outcomes
  • Identify possible myeloma symptoms and treatment for side effects management
  • Discuss survivorship issues for people living with myeloma

Speakers

Melissa Alsina, MD
Head, Multiple Myeloma Program
Associate Member, Department of Blood & Marrow Transplantation
H. Lee Moffitt Cancer Center &  Research Institute
Tampa, FL

Kathy A. Daily, RN, OCN
Multiple Myeloma Bone Marrow Transplant Coordinator/Primary Nurse
H. Lee Moffitt Cancer Center & Research Institute
Tampa, FL

Sponsors and Supporters

This program was sponsored by The Leukemia & Lymphoma Society and supported by grants from Celgene CorporationMillennium: The Takeda Oncology Company, and Onyx Pharmaceuticals, Inc.

last updated on Friday, November 30, 2012
btn_sharethis

Publications

Publications

A free resource provided by the National Institutes of Health - access more than 20 million biomedical literature citations.

Learn More